Axsome Therapeutics

New York, United States

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

$570.0M raised

May 2025

Post-IPO Debt

Biopharma Biotechnology Therapeutics

Top Investors

Blackstone Group Hercules Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Axsome Therapeutics

How much funding has Axsome Therapeutics raised?

Axsome Therapeutics has raised $570.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2025.

Who are Axsome Therapeutics's investors?

Axsome Therapeutics's investors include Blackstone Group, Hercules Capital.

Where is Axsome Therapeutics headquartered?

Axsome Therapeutics is headquartered in New York, United States.

What does Axsome Therapeutics do?

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

What stage is Axsome Therapeutics at?

Axsome Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2025.

MLA

"Axsome Therapeutics — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/axsome-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Axsome Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/axsome-therapeutics

Wikipedia (cite web)

{{cite web |title=Axsome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/axsome-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.